A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.